Sanofi (NASDAQ:SNY) to Post Q1 2024 Earnings of $0.94 Per Share, Leerink Partnrs Forecasts

Sanofi (NASDAQ:SNY - Free Report) - Investment analysts at Leerink Partnrs cut their Q1 2024 earnings per share (EPS) estimates for shares of Sanofi in a research note issued on Tuesday, April 16th. Leerink Partnrs analyst D. Risinger now forecasts that the company will post earnings per share of $0.94 for the quarter, down from their previous forecast of $0.98. The consensus estimate for Sanofi's current full-year earnings is $4.16 per share. Leerink Partnrs also issued estimates for Sanofi's FY2024 earnings at $3.97 EPS, FY2025 earnings at $4.44 EPS and FY2028 earnings at $5.34 EPS.

Sanofi (NASDAQ:SNY - Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing analysts' consensus estimates of $0.94 by ($0.05). The company had revenue of $11.76 billion during the quarter, compared to analysts' expectations of $13.02 billion. Sanofi had a return on equity of 27.47% and a net margin of 12.56%.

A number of other equities analysts have also recently commented on SNY. StockNews.com cut Sanofi from a "strong-buy" rating to a "buy" rating in a report on Tuesday, February 27th. Morgan Stanley began coverage on Sanofi in a report on Tuesday, January 23rd. They issued an "equal weight" rating and a $55.00 target price for the company. Finally, TheStreet lowered Sanofi from a "b" rating to a "c" rating in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $55.00.

Sanofi Trading Down 1.6 %

Shares of Sanofi stock traded down $0.72 on Thursday, reaching $45.39. The company had a trading volume of 4,359,545 shares, compared to its average volume of 1,897,695. The firm has a market cap of $114.82 billion, a price-to-earnings ratio of 19.23, a P/E/G ratio of 1.71 and a beta of 0.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The firm's 50-day moving average price is $47.52 and its two-hundred day moving average price is $48.67. Sanofi has a 1 year low of $42.63 and a 1 year high of $57.82.

Institutional Investors Weigh In On Sanofi

Institutional investors and hedge funds have recently modified their holdings of the business. Cardinal Capital Management raised its position in Sanofi by 0.3% during the 4th quarter. Cardinal Capital Management now owns 58,854 shares of the company's stock valued at $2,927,000 after purchasing an additional 201 shares in the last quarter. Daiwa Securities Group Inc. raised its position in Sanofi by 3.4% during the 4th quarter. Daiwa Securities Group Inc. now owns 6,541 shares of the company's stock valued at $325,000 after purchasing an additional 216 shares in the last quarter. Wynn Capital LLC raised its position in Sanofi by 4.5% during the 1st quarter. Wynn Capital LLC now owns 5,266 shares of the company's stock valued at $256,000 after purchasing an additional 226 shares in the last quarter. Sage Rhino Capital LLC increased its holdings in shares of Sanofi by 2.8% in the 3rd quarter. Sage Rhino Capital LLC now owns 8,722 shares of the company's stock valued at $468,000 after acquiring an additional 240 shares during the period. Finally, Angeles Investment Advisors LLC increased its holdings in shares of Sanofi by 2.1% in the 4th quarter. Angeles Investment Advisors LLC now owns 12,029 shares of the company's stock valued at $598,000 after acquiring an additional 244 shares during the period. 10.04% of the stock is owned by institutional investors.

Sanofi Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, June 6th. Investors of record on Friday, May 10th will be paid a dividend of $1.478 per share. This is a positive change from Sanofi's previous annual dividend of $1.38. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. Sanofi's dividend payout ratio (DPR) is currently 58.47%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.